NCT06759090 2025-01-06
Metronomic Capecitabine with Camrelizumab and Apatinib Mesylate for Treatment of Advanced Pancreatic Cancer
Zhejiang University
Phase 2 Not yet recruiting
Clinical Trials
5 trialsNCT04415385 2020-06-04
The Combination of Camrelizumab and Apatinib as Second-line Therapy for Advanced Pancreatic Carcinoma
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT04101929 2019-11-05
Apatinib, Irinotecan and S-1 (ApaIRIS) in Treating Patients With Metastatic Pancreatic Cancer After AG Regimen
Fudan University
Phase 2 Unknown
NCT02726854 2016-12-02
Apslpanc
First Affiliated Hospital Xi'an Jiaotong University
Phase 2 Unknown
NCT02863367 2016-08-11
OECTAPGAMPC
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown